TUMOR ANTIGEN

PROBLEM TO BE SOLVED: To provide a peptide having all the functions of a tumor antigen recognized by HLA-A2-restricted CTL or HLA-A24-restricted CTL, an antigen against the peptide, a compound having interaction with the peptide, a CTL-inducing agent comprising the peptide, a medicinal composition c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	ITO KYOGO
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	ITO KYOGO
description	PROBLEM TO BE SOLVED: To provide a peptide having all the functions of a tumor antigen recognized by HLA-A2-restricted CTL or HLA-A24-restricted CTL, an antigen against the peptide, a compound having interaction with the peptide, a CTL-inducing agent comprising the peptide, a medicinal composition containing one or more of these, a method of identification of a compound having interaction with the peptide, a method of inducing the CTL using the peptide, a method of determination of the peptide or the antigen and a reagent kit used in the method of identification and the method of determination. SOLUTION: Description are presented on the determination and the application of the tumor antigen peptide inducing HLA-A2-restricted CTL or HLA-A24-restricted CTL from the peripheral mononuclear blood cells of prostate cancer patients based on the amino acid sequences of protein PSA, PSM and PSCA known as markers for prostate cancer. COPYRIGHT: (C)2008,JPO&INPIT
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2007291112A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2007291112A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2007291112A3</originalsourceid><addsrcrecordid>eNrjZOANCfX1D1Jw9AvxdHf142FgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8V4BRgYG5kaWhoaGRo7GRCkCAOdpHRc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TUMOR ANTIGEN</title><source>esp@cenet</source><creator>ITO KYOGO</creator><creatorcontrib>ITO KYOGO</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a peptide having all the functions of a tumor antigen recognized by HLA-A2-restricted CTL or HLA-A24-restricted CTL, an antigen against the peptide, a compound having interaction with the peptide, a CTL-inducing agent comprising the peptide, a medicinal composition containing one or more of these, a method of identification of a compound having interaction with the peptide, a method of inducing the CTL using the peptide, a method of determination of the peptide or the antigen and a reagent kit used in the method of identification and the method of determination. SOLUTION: Description are presented on the determination and the application of the tumor antigen peptide inducing HLA-A2-restricted CTL or HLA-A24-restricted CTL from the peripheral mononuclear blood cells of prostate cancer patients based on the amino acid sequences of protein PSA, PSM and PSCA known as markers for prostate cancer. COPYRIGHT: (C)2008,JPO&INPIT</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071108&DB=EPODOC&CC=JP&NR=2007291112A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071108&DB=EPODOC&CC=JP&NR=2007291112A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ITO KYOGO</creatorcontrib><title>TUMOR ANTIGEN</title><description>PROBLEM TO BE SOLVED: To provide a peptide having all the functions of a tumor antigen recognized by HLA-A2-restricted CTL or HLA-A24-restricted CTL, an antigen against the peptide, a compound having interaction with the peptide, a CTL-inducing agent comprising the peptide, a medicinal composition containing one or more of these, a method of identification of a compound having interaction with the peptide, a method of inducing the CTL using the peptide, a method of determination of the peptide or the antigen and a reagent kit used in the method of identification and the method of determination. SOLUTION: Description are presented on the determination and the application of the tumor antigen peptide inducing HLA-A2-restricted CTL or HLA-A24-restricted CTL from the peripheral mononuclear blood cells of prostate cancer patients based on the amino acid sequences of protein PSA, PSM and PSCA known as markers for prostate cancer. COPYRIGHT: (C)2008,JPO&INPIT</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZOANCfX1D1Jw9AvxdHf142FgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8V4BRgYG5kaWhoaGRo7GRCkCAOdpHRc</recordid><startdate>20071108</startdate><enddate>20071108</enddate><creator>ITO KYOGO</creator><scope>EVB</scope></search><sort><creationdate>20071108</creationdate><title>TUMOR ANTIGEN</title><author>ITO KYOGO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2007291112A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ITO KYOGO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ITO KYOGO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TUMOR ANTIGEN</title><date>2007-11-08</date><risdate>2007</risdate><abstract>PROBLEM TO BE SOLVED: To provide a peptide having all the functions of a tumor antigen recognized by HLA-A2-restricted CTL or HLA-A24-restricted CTL, an antigen against the peptide, a compound having interaction with the peptide, a CTL-inducing agent comprising the peptide, a medicinal composition containing one or more of these, a method of identification of a compound having interaction with the peptide, a method of inducing the CTL using the peptide, a method of determination of the peptide or the antigen and a reagent kit used in the method of identification and the method of determination. SOLUTION: Description are presented on the determination and the application of the tumor antigen peptide inducing HLA-A2-restricted CTL or HLA-A24-restricted CTL from the peripheral mononuclear blood cells of prostate cancer patients based on the amino acid sequences of protein PSA, PSM and PSCA known as markers for prostate cancer. COPYRIGHT: (C)2008,JPO&INPIT</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_JP2007291112A
source	esp@cenet
subjects	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	TUMOR ANTIGEN
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A43%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ITO%20KYOGO&rft.date=2007-11-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2007291112A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true